Though increased expression levels of S100A7 and RAGE have been frequently observed in ER− breast cancer, our results demonstrate that S100A7 and RAGE expression levels could also be induced in ER+ breast cancer cells by an interaction with ASCs. Here, S100A7 is linked to breast cancer.